In 2021, the percentage of children and adolescents who received treatment or counseling from a mental health professional in the past year varied across the United States. Vermont was the state with the highest percentage of children and adolescents who received mental health treatment, while Hawaii was the lowest. Across the U.S. the average rate was **** percent. This graph shows the percentage of children and adolescents in United States aged **** who received treatment or counseling from a mental health professional in the past 12 months as of 2021.

In 2022, nearly ** percent of adults with any mental illness (AMI) in Indiana reported that they were not able to receive mental health-related treatment, the highest share across all states in the United States. On the other hand, West Virginia had the lowest share of adults in the U.S. who reported unmet mental health needs with **** percent. This statistic represents the share of adults with AMI who reported unmet needs for mental health treatment in the U.S. in 2022, by state.

A one-off statistical bulletin presenting key results from the National Drug Treatment Monitoring System (NDTMS) concerning people in contact with drug treatment agencies in England who are parents or who live with children under-18.

Source agency: National Treatment Agency

Designation: Official Statistics not designated as National Statistics

Language: English

Alternative title: Drug Treatment Activity

The Treatment Episode Data Set -- Admissions (TEDS-A) is a national census data system of annual admissions to substance abuse treatment facilities. TEDS-A provides annual data on the number and characteristics of persons admitted to public and private substance abuse treatment programs that receive public funding. The unit of analysis is a treatment admission. TEDS consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA.
A sister data system, called the Treatment Episode Data Set -- Discharges (TEDS-D), collects data on discharges from substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006.
TEDS variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)".
Variables in the MDS include: information on service setting, number of prior treatments, primary source of referral, sex, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008).
Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances.
Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances.This study has 1 Data Set.

BY: Tuberculosis Treatment Success Rate: % of New Cases data was reported at 87.000 % in 2022. This records an increase from the previous number of 84.000 % for 2021. BY: Tuberculosis Treatment Success Rate: % of New Cases data is updated yearly, averaging 85.000 % from Dec 2003 (Median) to 2022, with 20 observations. The data reached an all-time high of 93.000 % in 2005 and a record low of 71.000 % in 2011. BY: Tuberculosis Treatment Success Rate: % of New Cases data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Belarus – Table BY.World Bank.WDI: Social: Health Statistics. Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ('cured' and 'treatment completed' respectively).;World Health Organization, Global Tuberculosis Report.;Weighted average;Aggregate data by groups are computed based on the groupings for the World Bank fiscal year in which the data was released by the World Health Organization.

Increase the number of eligible children receiving mental health treatment from 87,500 in 2014 to 91,000 by 2018.

The Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) was launched in 2008 with a focus on conducting implementation research in criminal justice settings. NIDA's ultimate goal for CJ-DATS 2 was to identify implementation strategies that maximize the likelihood of sustained delivery of evidence-based practices to improve offender drug abuse and HIV outcomes, and to decrease their risk of incarceration. The Medication-Assisted Therapy (MAT) study focuses on implementing linkages to medication assisted treatment in correctional settings. During the study period community corrections staff engaged in training about addiction pharmacotherapies, while leadership in the corrections and treatment facilities engage in a joint strategic planning process to identify and resolve barriers to efficient flow of clients across the two systems. This study includes 28 datasets and over 1,400 variables. The first five datasets for this study contain data on the baseline characteristics of the treatment and corrections sites that participated in the study as well as the characteristics of the staff working at those facilities. Opinions about Medication Assisted Treatment surveys were administered to personnel at the participating corrections and treatment sites (D6). Data on Inter-organization Relations between Probation and Parole staff with Treatment Providers were also collected (DS7-DS18). Information was extracted from the charts of clients about their alcohol and opioid dependence as well as the referrals and treatment the clients received (DS19). Probation and parole officers and treatment providers were surveyed about monthly counts of referrals (DS20-DS21). During the study 10 staff members from the community corrections agency and local treatment providers where MAT services were available were nominated to participate in a Pharmacotherapy Exchange Council (PEC). PEC members were involved with strategic planning for implementing changes to improve the usage of Medication-Assisted Therapy. PEC members were surveyed several times throughout the study. PEC members completed surveys on how well the sites were adhering to the Organizational Linkages Intervention (OLI) process (DS22). Community corrections staff, PEC members and Connections Coordinators in the experimental group were surveyed about their perceptions of organizational benefits and costs associated with the MATICCE intervention (DS23). The PEC rated the Connections Coordinators (DS24)and the Connections Coordinators rate the PEC (DS25). PEC researchers completed surveys on how much of the OLI was completed (DS26) as well as what the sustainability of the changes made through the MATTICE project (DS27). The final dataset provides a key for who took the KPI (Key Performance Indicators) training and who was a PEC member (DS28).

The purpose of this project was to identify and abstract data from randomized controlled trials (RCTs) of posttraumatic stress disorder (PTSD) interventions to support the development of a publicly accessible data repository by the National Center for Posttraumatic Stress Disorder. The 2019 Report and Evidence Tables (Appendix E & F) are included in the downloadable .zip file. For more information, visit AHRQ's page, and look under "Previous Versions" tab: https://effectivehealthcare.ahrq.gov/products/ptsd-pharm-treatment/research

An online resource for locating mental health treatment facilities and programs supported by the Substance Abuse and Mental Health Services Administration (SAMHSA). The Mental Health Treatment Locator section of the Behavioral Health Treatment Services Locator lists facilities providing mental health services to persons with mental illness. It includes: Public mental health facilities that are funded by their State mental health agency (SMHA) or other State agency or department Mental health treatment facilities administered by the Department of Veterans Affairs, Private for-profit and non-profit mental health facilities that are licensed by the State or accredited by a national accreditation organization. NOTE: The Mental Health Treatment Locator does not include facilities whose primary or only focus is the provision of services to persons with Mental Retardation (MR), Developmental Disability (DD), and Traumatic Brain Injuries (TBI). Facilities that provide treatment exclusively to persons with mental illness who are incarcerated. Mental health professionals in private practice (individual) or in a small group practice not licensed or certified as a mental health clinic or (community) mental health center. SAMHSA endeavors to keep the Locator current. All information in the Locator is updated annually based on facility responses to SAMHSA's National Mental Health Services Survey (N-MHSS). The most recent complete update includes data collected as of April 30, 2010 in the N-MHSS. New facilities are added monthly. Updates to facility names, addresses, telephone numbers and services are made weekly, if facilities inform SAMHSA of changes. For additional advice, you may call the Referral Helpline operated by SAMHSA's Center for Substance Abuse Treatment: 1-800-662-HELP (English & Español) 1-800-487-4889 (TTY)

In 2023, there were some 4.3 million alcohol abuse-related treatments received by adults within the past year in the United States. Alcoholism refers to problems with alcohol and often refers to alcohol addiction. Alcohol has the potential to cause damage to all organs of the body. This statistic shows the number of alcohol abuse-related treatments received by adults within the past year in the United States from 2005 to 2023.

The U.S. Census Bureau, in collaboration with five federal agencies, launched the Household Pulse Survey to produce data on the social and economic impacts of Covid-19 on American households. The Household Pulse Survey was designed to gauge the impact of the pandemic on employment status, consumer spending, food security, housing, education disruptions, and dimensions of physical and mental wellness. The survey was designed to meet the goal of accurate and timely weekly estimates. It was conducted by an internet questionnaire, with invitations to participate sent by email and text message. The sample frame is the Census Bureau Master Address File Data. Housing units linked to one or more email addresses or cell phone numbers were randomly selected to participate, and one respondent from each housing unit was selected to respond for him or herself. Estimates are weighted to adjust for nonresponse and to match Census Bureau estimates of the population by age, gender, race and ethnicity, and educational attainment. All estimates shown meet the NCHS Data Presentation Standards for Proportions.

This study examined the relationship between legal pressure and drug treatment retention by assessing perceptions of legal pressure held by two groups of legally-mandated treatment clients: (1) participants of the Drug Treatment Alternative to Prison (DTAP) program operated by the Kings County (Brooklyn) District Attorney in New York City, and (2) a matched group of probationers, parolees, Treatment Alternatives to Street Crime (TASC) participants, and other court-mandated offenders attending the same community-based treatment programs used by DTAP. The Brooklyn DTAP was selected for study because of the program's uniquely coercive program components, including the threat of a mandatory prison term for noncompliance. The goals of this project were (1) to test whether DTAP participants would show significantly higher retention rates when compared to a matched sample of other legally-mandated treatment clients, and (2) to assess the role of perceived legal pressure in predicting retention for both of these groups. Data were collected from program participants through interviews conducted at admission to treatment and follow-up interviews conducted about eight weeks later. Intake interviews were conducted, on average, one week after the client's admission to treatment. The one-to-one interviews, which lasted up to two hours, were administered by trained researchers in a private location at the treatment site. The intake interview battery included a mixture of standardized measures and those developed by the Vera Institute of Justice. Data in Part 1 were collected with the Addiction Severity Index and include age, sex, race, religion, and education. Additional variables cover medical problems, employment history, detailed substance abuse and treatment history, number of times arrested for various crimes, history of incarceration, family's substance abuse and criminal histories, relationships with family and friends, psychological problems such as depression, anxiety, and suicide, current living arrangements, and sources of income. Part 2, Supplemental Background and Retention Data, contains treatment entry date, number of days in treatment, age at treatment entry, termination date, treatment condition, arrest date, detention at arrest, date released on probation/parole, violation of probation/parole arrest date and location, problem drug, prior drug treatment, as well as age, gender, race, education, and marital status. Part 3, Division of Criminal Justice Services Data, includes data on the number of arrests before and after program entry, and number of total misdemeanor and felony arrests, convictions, and sentences. Part 4, Chemical Use, Abuse, and Dependence Data, contains information on type of substance abuse, intoxication or withdrawal at work, school, or home, effects of abuse on social, occupational, or recreational activities, and effects of abuse on relationships, health, emotions, and employment. Parts 5 and 6 contain psychiatric data gathered from the Symptom Checklist-90-Revised and Beck's Depression Inventory, respectively. Part 7 variables from the Circumstances, Motivation, Readiness, and Suitability scale include family's attitude toward treatment, subject's need for treatment, subject's desire to change life, and legal consequences if subject did not participate in treatment. Part 8, Stages of Change Readiness and Treatment Eagerness scale, contains data on how the subject viewed the drug problem, desire to change, and history of dealing with substance abuse. Part 9, Motivational/Program Supplement Data, includes variables on the subject's need for treatment, attitudes toward treatment sessions, the family's reaction to treatment, and a likelihood of completion rating. Part 10, Perceived Legal Coercion Data, gathered information on who referred the subject to the treatment program, who was keeping track of attendance, whether someone explained the rules of participation in the program and the consequences if the subject failed the program, whether the rules and consequences were put in writing, who monitored program participants, the likelihood of using drugs while in treatment, the likelihood of leaving the program before completion, whether the subject understood the legal consequences of failing the program, the type and frequency of reports and contacts with the criminal justice system, and the subject's reaction to various penalties for not completing the program. Part 11 contains data from the Community Oriented Programs Environment Scale (COPES). Part 12, Treatment Services Review Data, includes data on the number of times the subject received medical attention, days in school, days employed, days intoxicated, days in substance abuse treatment, days tested for drugs, number of contacts with the criminal justice system, days treated for psychological problems, and time spent at recreational activities. Additional variables include the number of individual and group treatment sessions spent discussing medical problems, education and employment, substance abuse, legal problems, and psychological and emotional problems.

The Uniform Facility Data Set (UFDS) was designed to measure the scope and use of drug abuse treatment services in the United States. The survey collects information from each privately- and publicly-funded facility in the country that provides substance abuse treatment as well as from state-identified facilities that provide other substance abuse services. Data are collected on a number of topics including facility operation, services provided (assessment, therapy, testing, health, continuing care, special programs, transitional services, community outreach, ancillary), type of treatment, numbers of clients, and various client characteristics. The main objective of the UFDS is to produce data that can be used to assess the nature and extent of substance abuse treatment services, to assist in the forecast of treatment resource requirements, to analyze treatment service trends, to conduct national, regional, and state-level comparative analyses of treatment services and utilization, and to generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its on-line equivalent, the Substance Abuse Treatment Facility Locator http://findtreatment.samhsa.gov/.This study has 1 Data Set.

The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator http://findtreatment.samhsa.gov. Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, testing, transitional, and ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.This study has 1 Data Set.

Hydrographic and Impairment Statistics (HIS) is a National Park Service (NPS) Water Resources Division (WRD) project established to track certain goals created in response to the Government Performance and Results Act of 1993 (GPRA). One water resources management goal established by the Department of the Interior under GRPA requires NPS to track the percent of its managed surface waters that are meeting Clean Water Act (CWA) water quality standards. This goal requires an accurate inventory that spatially quantifies the surface water hydrography that each bureau manages and a procedure to determine and track which waterbodies are or are not meeting water quality standards as outlined by Section 303(d) of the CWA. This project helps meet this DOI GRPA goal by inventorying and monitoring in a geographic information system for the NPS: (1) CWA 303(d) quality impaired waters and causes; and (2) hydrographic statistics based on the United States Geological Survey (USGS) National Hydrography Dataset (NHD). Hydrographic and 303(d) impairment statistics were evaluated based on a combination of 1:24,000 (NHD) and finer scale data (frequently provided by state GIS layers).

NOTE: As of 12/17/2024, this dataset is no longer updated. Please use ASPR Treatments Locator.

This dataset displays pharmacies, clinics, and other locations with safe and effective COVID-19 medications. These medications require a prescription from a healthcare provider. Some locations, known as Test to Treat sites, give you the option to get tested, get assessed by a healthcare provider, and receive treatment – all in one visit. COVID-19 medications may be available at additional locations that are not shown in this dataset.

The locations displayed have either self-attested they have inventory of Paxlovid (nirmatrelvir packaged with ritonavir), Lagevrio (molnupiravir), or Veklury (Remdesivir) within at least the last two months and/or reported participation in the Paxlovid Patient Assistance Program. Sites that have not reported in the last two weeks display a notification, "Inventory has not been reported in the last 2 weeks. Please contact the provider to make sure the product is available." Outpatient COVID-19 medications may be available at additional locations not listed on this website.

All therapeutics identified in the locator not approved by the FDA must be used in alignment with the terms of the respective product’s Emergency Use Authorization. Visit COVID-19 Treatments and Therapeutics for more information on all treatment options.

This website identifies sites that have commercially purchased inventory of COVID-19 treatments and, in some cases, may identify sites that have remaining, no-cost U.S. government distributed supply. Some sites may charge for services not covered by insurance. Some sites may offer telehealth services. This website is intended for informational purposes only and does not serve as an endorsement or recommendation for use of any of the locations listed on the sites.

Clarification for DoD Facilities: Those individuals eligible for care in an MTF include Active Duty Service Members (ADSMs), covered beneficiaries enrolled in TRICARE Prime or Select, including TRICARE Reserve Select (TRS), TRICARE Retired Reserve (TRR) and TRICARE Young Adult (TYA) participants, TRICARE for Life beneficiaries, and individuals otherwise entitled by law to MTF care (e.g., regular retired members and their dependents who are not enrolled in TRICARE but who are otherwise eligible for MTF space-available care, certain foreign military members and their families registered in DEERS, and others).

US: Tuberculosis Treatment Success Rate: % of New Cases data was reported at 83.000 % in 2015. This records a decrease from the previous number of 85.000 % for 2014. US: Tuberculosis Treatment Success Rate: % of New Cases data is updated yearly, averaging 83.000 % from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 86.000 % in 2008 and a record low of 62.000 % in 2009. US: Tuberculosis Treatment Success Rate: % of New Cases data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ('cured' and 'treatment completed' respectively).; ; World Health Organization, Global Tuberculosis Report.; Weighted average;